Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Keeps The Approval Hitting Streak Alive With Another Infield Single
Go back to Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Keeps The Approval Hitting Streak Alive With Another Infield Single| Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) | Delayed: 43.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.49 | 52 Week High | $43.51 | |||
| Open | $22.67 | 52 Week Low | $43.15 | |||
| Day High | $43.49 | P/E | 85.27 | |||
| Day Low | $43.49 | EPS | $0.51 | |||
| Volume | 10,279,079 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 274.29 +3.18 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $271.11 | 52 Week High | $126.07 | |||
| Open | $273.00 | 52 Week Low | $94.28 | |||
| Day High | $276.47 | P/E | 57.02 | |||
| Day Low | $270.56 | EPS | $4.81 | |||
| Volume | 2,336,773 | |||||
